Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2025-12-29 @ 12:37 PM
Study NCT ID:
NCT05509595
Status:
COMPLETED
Last Update Posted:
2025-01-22
First Post:
2022-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia
Sponsor:
National Institute of Dental and Craniofacial Research (NIDCR)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-18
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-19
First Submit QC Date:
None
Study First Post Date:
2022-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-18
Last Update Post Date:
2025-01-22
Last Update Post Date Type:
ACTUAL